Articles | EuroIntervention

10.4244/EIJV7I10A193 • Feb 21, 2012

Technique and outcome of ostial common carotid artery stenting: a single centre experience

Cam A, Muhammad K, Shishehbor M, Bajzer C, Kapadia S

free

10.4244/EIJV7I10A194 • Feb 21, 2012

High-speed intracoronary optical frequency domain imaging: implications for three-dimensional reconstruction and quantitative analysis

Okamura T, Onuma Y, Garcia-Garcia H, Bruining N, Serruys PW

free

10.4244/EIJV7I10A195 • Feb 21, 2012

In vivo characterisation of bioresorbable vascular scaffold strut interfaces using optical coherence tomography with Gaussian line spread function analysis

Sheehy A, Gutiérrez-Chico J-L, Diletti R, Oberhauser J, Glauser T, Harrington J, Kossuth M, Rapoza R, Onuma Y, Serruys PW

free

10.4244/EIJV7I10A196 • Feb 21, 2012

Physiological assessment of coronary haemodynamics: fractional flow reserve and beyond

Myat A, Asrress K, McConkey H, Redwood S

free

10.4244/EIJV710A197 • Feb 21, 2012

How should I treat an entrapped rotational atherectomy burr?

De Vroey F, Velavan P, Jack S, Webster M

free

10.4244/EIJV7I9A160 • Jan 20, 2012

How to remain focussed in a globalised world

Serruys PW

free

10.4244/EIJV7I9A161 • Jan 20, 2012

It’s time to say goodbye... (to the first-generation drug-eluting stent era)

Jørgensen E, Kelbæk H

free

10.4244/EIJV7I9A162 • Jan 20, 2012

Repetita iuvant (repeating helps): why another paper on a new stent is important

Sangiorgi G, Biondi-Zoccai G, Modena M

free

10.4244/EIJV7I9A163 • Jan 20, 2012

Young interventionalists

Fajadet J

free

10.4244/EIJV7I9A164 • Jan 20, 2012

Five-year clinical follow-up from the MISSION! Intervention Study: sirolimus-eluting stent versus bare metal stent implantation in patients with ST-segment elevation myocardial infarction, a randomised controlled trial

Boden H, van der Hoeven B, Liem S-S, Atary J, Cannegieter S, Atsma D, Bootsma M, Jukema J, Zeppenfeld K, Oemrawsingh P, van der Wall E, Schalij M

free

10.4244/EIJV7I9A165 • Jan 20, 2012

Predictors of early and late outcomes after everolimus and paclitaxel-eluting coronary stents

Applegate R, Hermiller J, Gordon P, Yaqub M, Sood P, Su X, Cao S, Sudhir K, Stone GW

free

10.4244/EIJV7I9A166 • Jan 20, 2012

Clinical long-term outcome after implantation of titanium nitride-oxide coated stents compared with paclitaxel- or sirolimus-eluting stents: propensity-score matched analysis

Limacher A, Räber L, Laube E, Lauterburg A, Lötscher S, Hess N, Moschovitis A, Baldinger S, Wenaweser P, Meier B, Hess O, Jüni P

free

10.4244/EIJV7I9A167 • Jan 20, 2012

A comparative analysis of major clinical outcomes with drug-eluting stents versus bare metal stents in male versus female patients

Kornowski R, Vaknin-Assa H, Assali A, Lev E, Porter A, Battler A, Bental T

free

10.4244/EIJV7I9A168 • Jan 20, 2012

Four-year clinical follow-up of the ABSORB everolimus-eluting bioresorbable vascular scaffold in patients with de novo coronary artery disease: the ABSORB trial

Dudek D, Onuma Y, Ormiston J, Thuesen L, Miquel-Hebert K, Serruys PW

free

10.4244/EIJV7I9A169 • Jan 20, 2012

Safety and effectiveness of the Catania Polyzene-F coated stent in real world clinical practice: 12-month results from the ATLANTA 2 registry

Tamburino C, Capodanno D, Di Salvo M-E, Sanfilippo A, Cascone I, Incardona V, Longo G, Giacoppo D, Capranzano P, Sgroi C, Ussia G, Monaco A, La Manna A

free